LATEST NEWS

San Diego biotech entrepreneurs François Ferré, Ph.D., and Magda Marquet, Ph.D., knew supporting LJI would be critical for advancing our understanding of COVID-19.
The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.
Karen Barnes reflects on a career in science—from tracking elephants to supporting LJI research
New study highlights VP40 as a promising therapeutic target
How Ian Mathews used Tullie and Rickey Families SPARK Awards funding to make cancer therapy advances and launch a career in medicine
Reactions reflect unique features of an individual’s immune system, not the strength of a response
Antibodies can change to counter new forms of the shape-shifting virus, research hints
San Diego artist Patricia Pauchnick on how she assembled her illustration for the Immune Matters magazine article "How Pandemics End"
The rapid rise in different parts of the world of deadly, more infectious coronavirus variants that share new mutations is leading scientists to ask a critical question
New LJI research could guide the development of more effective cancer immunotherapies
New funding will support high-risk, high-reward projects led by two early-career scientists